Atea Pharmaceuticals Provides Update and Topline Results for Phase 2 MOONSONG Trial Evaluating AT-527 in the Outpatient Setting
Go back to Atea Pharmaceuticals Provides Update and Topline Results for Phase 2 MOONSONG Trial Evaluating AT-527 in the Outpatient Setting| (NASDAQ: AVIR) | Delayed: 4.74 -0.25 (5.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.99 | 52 Week High | $2.00 | |||
| Open | $4.96 | 52 Week Low | $1.15 | |||
| Day High | $5.01 | P/E | N/A | |||
| Day Low | $4.71 | EPS | $0.00 | |||
| Volume | 193,977 | |||||
